If you're tired of temporary relief with artificial tears and looking for up to 24-hour relief from your moderate to severe dry eye symptoms, ask your doctor about LACRISERT (hydroxypropyl cellulose ophthalmic insert).
LACRISERT (hydroxypropyl cellulose ophthalmic insert) is a sterile, translucent, rod-shaped, water soluble, preservative-free, slow-release, prescription lubricant which is placed in your eye to treat moderate to severe dry eye symptoms and offers once-daily dosing. (Some people may need to use it twice a day for symptom relief.)
LACRISERT softens as it dissolves slowly over the course of one day to stabilize and thicken the tear film of the eye.1 This allows your natural tears to be better maintained throughout the day.2 As your tear film thickens, it can protect the surface of your eyes longer, and you should begin to feel relief from your dry eye symptoms.1
LACRISERT has been proven to relieve the following symptoms of moderate to severe dry eye1,2: dryness, burning, tearing, foreign body sensation, itching, light sensitivity, and blurred vision. Individual results may vary. It also can be used to treat the following eye conditions: exposure keratitis, decreased corneal sensitivity and recurrent corneal erosions. If you have further questions, please ask your eye care professional.
Please see Important Safety Information below.
*Individual results may vary.
- Once a day for most people
- Continuous lubrication over the course of a day*
Directions for use:
See full instructions > > (1.3 MB, PDF)
Instant Savings Offer
Pay NO MORE THAN $35*. Most eligible commercially insured patients pay no more than $35 co-pay for 1st prescription and eligible refills. Exclusively at Walgreens and other participating independent pharmacies.
Discounted pricing is also available for eligible uninsured patients.*
Click below for program:
If you have any questions regarding your eligibility or benefits, please call 1-855-280-0580.
*This offer is only valid for patients with commercial insurance and eligible uninsured patients.This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. This offer is good only in the U.S. at retail pharmacies owned and operated by Walgreen Co. (or its affiliates) or other participating independent retail pharmacies. This offer is not valid in Massachusetts or Minnesota or where otherwise prohibited, taxed or otherwise restricted.
Click here for all eligibility criteria and terms and conditions that apply.
LACRISERT (hydroxypropyl cellulose ophthalmic insert): Additional information
LACRISERT (hydroxypropyl cellulose ophthalmic insert) is an insert placed in your eye to treat moderate to severe dry eyes. It also can be used to treat the following eye conditions: exposure keratitis, decreased corneal sensitivity and recurrent corneal erosions.
Important Safety Information
Do not use LACRISERT (hydroxypropyl cellulose ophthalmic insert) if you are allergic to hydroxypropyl cellulose.
Follow the instructions for using LACRISERT that come with the package.
Because LACRISERT may cause temporary blurred vision, use caution when driving or operating machinery.
The following side effects have been reported: temporary blurring of vision, discomfort, irritation or redness in the eye, matting or sticky eyelashes, eye sensitivity to light, an allergic reaction known as hypersensitivity and swelling of the eyelid.
Tell your doctor about any side effects that you may have.
Please see complete Prescribing Information for LACRISERT (466.5 KB, PDF).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
*Offer varies at cash-only pharmacies, see terms and conditions for details
[prescribing information]. Lawrenceville, NJ: Aton Pharma, Inc; 2008.
Katz JI, Kaufman HE, Breslin C, Katz IM. Slow-release artificial tears and the treatment of keratitis sicca. Ophthalmology. 1978;85(8):787-793.